• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2004

View Archived Issues

Fluvastatin XL reduces coronary artery disease risk factor in diabetic patients

Read More

Protective effects of palifermin during chemotherapy/radiotherapy

Read More

Two series of DPP-IV inhibitors prepared and tested at Tanabe Seiyaku

Read More

Pfizer describes new CDK2/CDK4 inhibitors with utility in cancer therapy

Read More

Novartis and Scripps jointly describe new antitumor epothilones

Read More

Two novel series of GABA-A receptor ligands developed at Merck

Read More

New GSK-3beta inhibitors in early development at Mitsubishi Pharma

Read More

New tyrosine kinase inhibitors emerge from Merck R&D

Read More

Monoclonal antibody with broad HIV-neutralizing activity identified by NIH and NCI

Read More

Targeting IkappaB kinase for inflammation and pain therapy

Read More

European Commission approves extended labeling for Xenical

Read More

Positive phase III results for Velac

Read More

Allowance of IND for clinical testing of new HIV vaccine

Read More

Structural GenomiX enters drug discovery collaboration with Serono

Read More

Norak BioSciences completes screening collaboration with Sumitomo

Read More

IND filing for DB-289 as oral treatment for African sleeping sickness

Read More

Health Discovery and U. of Miami enter AIDS-related dementia agreement

Read More

Pamorelin LA receives approval in Germany

Read More

Orphan drug status for sodium thiosulfate

Read More

Encouraging preclinical data reported for glucosylceramide

Read More

European orphan drug status for Anatibant

Read More

New European phase II/III trial for Bexidem in bladder cancer

Read More

INDs filed for topical PEP-005

Read More

Fosrenol receives approval in Sweden

Read More

Comparative monkey studies successfully completed for Belerofon

Read More

Phase III results for anidulafungin plus liposomal amphotericin B

Read More

Interim data from HuMax-IL-15 phase II study in RA

Read More

Doxycycline hyclate reported safe and effective for rosacea

Read More

Effective maintenance of asthma control with a fluticasone propionate/salmeterol combination

Read More

Improved asthma control achieved with Symbicort single inhaler therapy

Read More

Olopatadine significantly improves the quality of life of patients with SAR

Read More

Low incidence of oropharyngeal side effects found with ciclesonide in asthma

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe